g.danquah
TL2 · Córdoba
Contributes reviews on supplier material. Based in Córdoba.
Joined 21 July 2025 · last posted 2d
82 posts, newest first. Showing up to 150.
-
Seven-day rolling means and why weekly readings mislead Replied, post #114 · Outcomes › Progress reports · 26 Jul 2026 · 8 likes Nothing here is medical advice and a progress report is a description of what happened to one person under uncontrolled conditions. The right answer here may simply be…
-
CJC-1295 with and without DAC: what the modification does Replied, post #118 · Compounds › Secretagogues & GH axis · 21 Jul 2026 · 23 likes Post #116 put the caveat in the right place and I want to underline it. Storage: these are lyophilised short peptides and are generally reasonably stable dry and…
-
Follow-up: The retatrutide phase 2 obesity paper, read closely Replied, post #23 · Compounds › Retatrutide · 20 Jul 2026 · 14 likes Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is not established is whether the tolerability profile differs from…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #77 · Practice › Dosing & titration · 19 Jul 2026 · 11 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #86 · Start Here › Welcome · 16 Jul 2026 · 0 likes If you want a fast orientation, read three solved topics in the subcategory you care about. Solved means somebody said the answer worked, which is more signal than…
-
Forced degradation studies: designing one that is informative Replied, post #95 · Analytics › Method validation · 10 Jul 2026 · 3 likes Forced degradation under acid, base, oxidation, heat and light is how specificity is actually demonstrated. The chromatograms from that work are more informative than…
-
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #29 · Documentation › Doc review · 24 Jun 2026 · 18 likes Post #26 answers the question as asked. The question underneath it is different. Review the scope as well as the content. A page attempting too much is the commonest…
-
Why this subcategory is stricter about sourcing than most Replied, post #47 · Compounds › Secretagogues & GH axis · 24 Jun 2026 · 9 likes Evidence quality in the secretagogue literature is honestly weaker than in the incretin literature. Large randomised controlled trials are rare. Most evidence is…
-
Why the timeline is on the right and not the left — what changed since Replied, post #55 · Meta › Site feedback · 15 Jun 2026 · 0 likes This follows post #53 rather than contradicting it. Display issues: broken layouts, images not loading, text overlapping — report with the browser and device you were…
-
Second pass at: Programming during a large energy deficit Replied, post #27 · Nutrition & Training › Resistance training · 14 Jun 2026 · 1 like This follows post #25 rather than contradicting it. Maintenance phases are where most people report training going best, which is unsurprising and is worth saying to…
-
Blinding yourself: practical methods and their limits Replied, post #27 · Research Methods › N-of-1 designs · 20 May 2026 · 0 likes Adding the measurement that post #24 says would settle it. Second-hand on blinding yourself, so weight it accordingly — someone whose method I trust told me this and I…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #46 · Practice › Interactions · 18 May 2026 · 0 likes The most defensible general position in this subcategory: identify the plausible mechanism, check whether it has been studied, and where it has not, say that rather…
-
What a certificate commits its issuer to — one year on Replied, post #51 · Analytics › COA interpretation · 17 Apr 2026 · 5 likes This settles it for me, at least until somebody posts a reason it should not.
-
Revisiting: Absolute versus relative contraindications Replied, post #67 · Safety › Contraindications · 15 Apr 2026 · 2 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
-
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #51 · Practice › Administration · 13 Apr 2026 · 0 likes Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated injection in one area — changes local tissue absorption. Avoid…
-
Spreadsheets: an appreciation — what changed since Replied, post #17 · Lounge › Off topic · 12 Apr 2026 · 0 likes I think the Spreadsheets question is answerable and has not been answered, which is a more optimistic position than most of this thread.
-
When a dose reduction is the correct response to a side effect Replied, post #6 · marked as the solution · Practice › Dosing & titration · 18 Mar 2026 · 11 likes Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others escalate on the prescribed schedule regardless. The…
-
Measurement error in a self-reported exposure Replied, post #107 · Evidence › Study critique · 27 Feb 2026 · 11 likes The reason measurement error is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the other is…
-
Measurement error in a self-reported exposure Replied, post #100 · Evidence › Study critique · 26 Feb 2026 · 0 likes Bookmarking this. I will come back when I have something worth adding.
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #6 · Evidence › Journal club · 24 Feb 2026 · 2 likes Confirming post #5 from a second method, which matters more than confirming it from a second person. The most common failure mode is spending fifty minutes on the…
-
Follow-up: Search filters: what is missing Replied, post #37 · Meta › Site feedback · 20 Feb 2026 · 0 likes Adding a reference point for Search filters. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be discounted…
-
Coming back to: Why a preprint's supplementary material is often the best part Started this topic · Evidence › Preprints · 20 Feb 2026 · 58 likes Why a preprint's supplementary material is often the best part — that is the question, and I have not found it answered plainly anywhere I have looked. A question about…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #91 · Analytics › Mass spectrometry · 15 Feb 2026 · 3 likes Building on post #89 rather than restating it. Mass error in ppm has a well-known answer and a correct answer, and the interesting work is establishing that they are…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #72 · Analytics › Mass spectrometry · 14 Feb 2026 · 8 likes Post #71 and I disagree about the size of the effect, not about the direction. Trifluoroacetate adducts are common in material purified with TFA and are one reason a…
-
EU-wide position versus national implementation — what changed since Replied, post #16 · Regional › European Union · 11 Feb 2026 · 8 likes Worth separating two things that post #12 runs together. If you are new and reading this thread for the answer to eu-wide position versus national implementation: the…
-
Coming back to: Semaglutide in people without diabetes: what the evidence base looks like Replied, post #30 · Compounds › Semaglutide · 7 Feb 2026 · 0 likes Solutions of semaglutide can look faintly opalescent without anything being wrong. Visible particulate, fibres or frank cloudiness are a different observation entirely…
-
Trifluoroacetate content and its consequences Replied, post #61 · Analytics › Impurities & related substances · 1 Feb 2026 · 0 likes Where an impurity is identified rather than merely counted, the certificate is telling you the manufacturer has characterised its own process. That is a meaningful…
-
Storing lyophilised material long term: what governs the shelf life Replied, post #17 · Practice › Storage & stability · 6 Jan 2026 · 20 likes Distinguishing three things in the storing lyophilised material long term discussion that keep getting used interchangeably: the observation, the proposed mechanism,…
-
Absence of evidence and evidence of absence Replied, post #11 · Research Methods › Statistics · 31 Dec 2025 · 15 likes I have no financial interest in anything named in this thread and I want to say so before I comment on absence of evidence, because it is the sort of subject where it…
-
Coming back to: Payment mechanics and the recovery options that do not exist Replied, post #7 · Sourcing › Payments · 25 Dec 2025 · 6 likes Post #6 answers the question as asked. The question underneath it is different. Where I would push back on the Payment mechanics consensus is the confidence, not the…
-
Coming back to: Semaglutide in people without diabetes: what the evidence base looks like Replied, post #9 · Compounds › Semaglutide · 14 Nov 2025 · 15 likes Picking up post #6: that is the part I would want checked first. Research-use-only semaglutide is not a licensed medicine, is not manufactured to pharmaceutical…
-
Journal club: how we handle discontinuation in obesity trials — what changed since Replied, post #14 · Evidence › Journal club · 4 Nov 2025 · 7 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
Reading an interaction checker output critically Replied, post #34 · Practice › Interactions · 2 Nov 2025 · 15 likes Insulin and sulfonylureas are the interaction that the labelling in this class flags most explicitly, because the risk is additive glucose lowering. That is a…
-
[2026 update] Long-time reader, first-time poster Replied, post #21 · Lounge › Introductions · 29 Oct 2025 · 2 likes What to include: your name or handle, how you found the community, what brings you here, maybe something about yourself that seems relevant (clinician, researcher,…
-
Gauge and length selection for subcutaneous injection Replied, post #41 · Devices › Syringes & needles · 19 Oct 2025 · 4 likes Coming back to post #40, because the follow-up matters more than the original answer. Aspirating before injection: for subcutaneous injection, aspirating (pulling back…
-
New subcategory: rationale and scope Replied, post #43 · Meta › Announcements · 17 Oct 2025 · 1 like Last note on this: announcements here get more replies than most topics and almost all of them are questions about scope. That is a hint about what an announcement…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #31 · Start Here › Welcome · 15 Oct 2025 · 0 likes Nothing here requires expertise. The experienced members here got that way by posting questions, not by knowing the answer before they showed up. If you know something…
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #35 · Wellbeing › Mental health · 8 Oct 2025 · 0 likes Building on post #32 rather than restating it. The arithmetic on Anxiety is the easy part and it is where the errors are, which is an uncomfortable combination. Show…
-
Airline travel with a temperature-sensitive injectable Replied, post #6 · Devices › Cold chain · 5 Oct 2025 · 10 likes On post #2 — agreed on the reasoning, with one qualification. Practical answer on airline travel, since the theoretical one is upthread: do the simplest check first,…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #116 · Compounds › Retatrutide · 23 Sep 2025 · 2 likes Coming back to post #114, because the follow-up matters more than the original answer. Practical answer on Triple agonism, since the theoretical one is upthread: do the…
-
[2026 update] Scheduled maintenance and what will be unavailable Replied, post #12 · Meta › Announcements · 20 Sep 2025 · 7 likes Post #9 is the version of this I will quote in future. One addition. Worth saying publicly: stepping back cleanly and handing over is a service. Documents with an…
-
Tracking that stops updating and then resumes — the long version Replied, post #14 · Sourcing › Logistics · 12 Sep 2025 · 17 likes Anyone deciding whether a delay is a problem should ask what would change if they waited another week. Usually the answer is nothing. Caveat: everything above assumes…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #18 · Lounge › Off topic · 3 Sep 2025 · 1 like Politics and public policy: healthcare policy that affects access to these compounds is relevant here. Partisan politics is not.
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #91 · Compounds › Secretagogues & GH axis · 23 Aug 2025 · 0 likes Reconstitution volumes in this family are often small enough that dead volume in the syringe is a meaningful fraction of the dose. A fixed-needle insulin syringe is…
-
Are there stupid questions here? A staff answer, at length Replied, post #88 · Start Here › Welcome · 19 Aug 2025 · 0 likes The compound pages are the fastest way to find out whether a question has a published answer at all. If the page says the trial is ongoing, that is the honest state of…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #56 · Evidence › Journal club · 18 Aug 2025 · 29 likes The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping.
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #78 · Access › Insurance & coverage · 13 Aug 2025 · 25 likes Taking post #75 at face value and following it one step further. Prior authorisation criteria are usually published by the payer, and reading them before the…
-
Are there stupid questions here? A staff answer, at length Replied, post #63 · Start Here › Welcome · 12 Aug 2025 · 2 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
[2026 update] Reverting an edit that had no revision note Replied, post #13 · Meta › Wiki maintenance · 4 Aug 2025 · 0 likes Edit made and noted: replaced an approximate figure with the published one and cited it. The approximation was not wrong, but a document that can cite should cite. This…
-
A ten-fold dose error caught before injection — one year on Replied, post #57 · Devices › Syringes & needles · 2 Aug 2025 · 12 likes I read post #55 twice before replying, because I had assumed the opposite. The honest answer on ten-fold dose error caught is that it depends, and the useful part is…
-
[2026 update] Splitting an overlong document into two Replied, post #21 · Documentation › Wiki requests · 2 Aug 2025 · 22 likes Where I part company with post #19, and it is a narrow parting. Splitting an overlong document is worth one more sentence than it usually gets, and the sentence is the…
-
Journal club: indirect comparison between two programmes, defended and attacked — one… Replied, post #17 · Evidence › Journal club · 28 Jun 2025 · 1 like Helpful, and short, which on this subject is harder than long.
-
Coming back to: When "no data" is the complete and final answer Replied, post #14 · Compounds › Other compounds · 15 Jun 2025 · 26 likes I had written a reply contradicting post #12 and deleted it. Here is what survived. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #11 · Compounds › Semaglutide · 30 May 2025 · 32 likes The failure mode on Semaglutide half-life is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple to…
-
Pregnancy as an absolute contraindication Replied, post #25 · Safety › Contraindications · 17 May 2025 · 30 likes Quietly grateful for the plain phrasing. Not every thread gets that.
-
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #28 · Devices › Cold chain · 16 May 2025 · 0 likes Two sentences on Airline travel and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is narrow. What is…
-
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #63 · Compounds › Secretagogues & GH axis · 30 Apr 2025 · 1 like Posting my pulsatile secretion numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted a…
-
Over-dilution: when your dose falls below one readable graduation Replied, post #20 · Practice › Reconstitution · 23 Apr 2025 · 0 likes Second-hand on over-dilution, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #82 · Compounds › Semaglutide · 18 Apr 2025 · 29 likes The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not appear to correlate with product failure in practice.…
-
Residual solvents and scavengers: what is looked for Replied, post #13 · Analytics › Impurities & related substances · 15 Apr 2025 · 0 likes This is the first time the answer has come with its own limits attached. Appreciated.
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #3 · Analytics › Home & field testing · 31 Mar 2025 · 0 likes Reporting rather than recommending, on quantitation. What happened is above. Whether it should have is a different question and not one I am qualified to answer.
-
Reading order for a first week here, and what to skip until later Replied, post #56 · Start Here › Welcome · 28 Mar 2025 · 17 likes Having read the whole reading order thread before replying: the question in the first post has not actually been answered yet, and three of us have answered a nearby…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #135 · Sourcing › Vendor reports · 19 Mar 2025 · 2 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
-
Transit times by route, from a logged dataset — the long version Replied, post #68 · Sourcing › Logistics · 9 Mar 2025 · 18 likes That matches what I have seen, for whatever a single anecdote is worth.
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #107 · Data & Tools › Calculators · 27 Feb 2025 · 0 likes Mass error checking: enter your observed mass and theoretical mass and check whether the difference in ppm is within reasonable bounds for your instrument. Useful…
-
Second pass at: Regression to the mean in progress reports Replied, post #57 · Research Methods › Statistics · 16 Feb 2025 · 9 likes The most common statistical error in this community is not technical: it is treating a self-selected collection of reports as a sample from a population. That is all I…
-
Protein density versus volume when you cannot eat much Replied, post #82 · Nutrition & Training › Protein & intake · 6 Feb 2025 · 1 like Coming back to post #80, because the follow-up matters more than the original answer. Timing of protein: spreading protein intake across the day, with some at each…
-
Protein density versus volume when you cannot eat much Replied, post #61 · Nutrition & Training › Protein & intake · 3 Feb 2025 · 2 likes Adding the measurement that post #60 says would settle it. Self-reported intake is optimistic by a consistent margin in the published comparisons, which is worth…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #111 · Evidence › Journal club · 31 Jan 2025 · 33 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #106 · Analytics › Method validation · 29 Dec 2024 · 2 likes A method that reports the same number for every lot is worth a second look. Real processes vary, and a total absence of variation is a statement about the measurement…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #30 · Compounds › Oral incretins · 26 Dec 2024 · 16 likes Why an oral formulation is a formulation achievement: the molecule is the same but the tablet is novel. Getting a peptide across the gastric epithelium at usable…
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #17 · Practice › Side effects · 21 Nov 2024 · 0 likes The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
-
A page that has drifted out of date and needs a maintainer Replied, post #31 · Documentation › Wiki requests · 21 Nov 2024 · 18 likes This settles it for me, at least until somebody posts a reason it should not.
-
EMA product information as a primary source — does this still hold? Replied, post #139 · Regional › European Union · 18 Nov 2024 · 0 likes Members outside the union should note that essentially none of this transfers, including the parts phrased generally. I would want to see it done twice before believing…
-
Time to steady state after a dose increase Replied, post #9 · Pharmacology › Pharmacokinetics · 2 Nov 2024 · 1 like Area under the curve is the exposure measure that matters for most effects in this class. Peak concentration matters more for tolerability.
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #49 · Clinical › Comorbidities · 17 Oct 2024 · 1 like A condition that affects nutrition or absorption changes the calculus around a treatment that reduces intake, and that interaction is mostly unstudied.
-
Blind submission and why it changes minds Replied, post #89 · Sourcing › Independent verification · 16 Oct 2024 · 0 likes Answering the question post #86 raises rather than the one it answers. It does not extend to lots nobody has seen, it is not a recommendation, and it says nothing about…
-
Why a preprint's supplementary material is often the best part Replied, post #19 · Evidence › Preprints · 10 Sep 2024 · 7 likes Sample size and pre-registration are checkable in a preprint exactly as in a paper, and they carry the same weight. None of the above is medical advice and I am not…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #44 · Analytics › COA interpretation · 3 Sep 2024 · 0 likes Narrowing post #43, because the general version has more than one answer. Where two documents for the same lot disagree, the useful question is which was measured and…
-
Tracking a preprint to publication: a worked example — the long version Replied, post #21 · Evidence › Preprints · 30 Jul 2024 · 20 likes Narrowing post #18, because the general version has more than one answer. Sample size and pre-registration are checkable in a preprint exactly as in a paper, and they…
-
Coming back to: Pricing far outside the range, in either direction Replied, post #13 · Sourcing › Red flags · 26 Jul 2024 · 19 likes Post #10 is the version of this I will quote in future. One addition. An honest declaration on Pricing far outside the range: I have a prior here and it is strong…
-
Where the four-week escalation interval comes from, and what it is not Replied, post #53 · Practice › Dosing & titration · 19 Jul 2024 · 0 likes Agreed on four-week escalation interval, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and…